The Marijuana Herald - Marijuana news and information A new study published in the Journal of Neurology found that a treatment containing 2.7 mg of THC and 2.5 mg of CBD was associated with significant reductions in restless legs syndrome severity, with improvements maintained for up to one year among patients who remained on the therapy. The study was conducted by researchers from Universidad Europea de Madrid and Hospital Universitario de Geta…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.